Businessweek

Zenotech Laboratories Limited engages in the development, manufacture, and marketing of generic biopharmaceuticals worldwide. The company manufactures recombinant DNA products from bacterial, yeast, and mammalian cells. It offers Nugraf, Macrogen, and IL-2, as well as generic chemical products in the therapeutic area of oncology. The company is also developing biological entities in the areas of cancer and neurology. In addition, it offers contract manufacturing services for generating and characterizing recombinant proteins, as well as functional validated assays in cell-based and cell-free formats for use in drug discovery. The company was formerly known as Sunline Technologies Limited and changed its name to Zenotech Laboratories Limited in August 2004. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.